These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 23748389
21. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
22. Ongoing measles outbreak in Romania, 2011. Stanescu A, Janta D, Lupulescu E, Necula G, Lazar M, Molnar G, Pistol A. Euro Surveill; 2011 Aug 04; 16(31):. PubMed ID: 21871218 [Abstract] [Full Text] [Related]
23. Measles in children vaccinated with 2 doses of MMR. Defay F, De Serres G, Skowronski DM, Boulianne N, Ouakki M, Landry M, Brousseau N, Ward BJ. Pediatrics; 2013 Nov 04; 132(5):e1126-33. PubMed ID: 24144708 [Abstract] [Full Text] [Related]
24. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. JAMA; 1990 May 09; 263(18):2467-71. PubMed ID: 2278542 [Abstract] [Full Text] [Related]
25. Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014. Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, van Binnendijk RS. J Infect Dis; 2016 Dec 15; 214(12):1980-1986. PubMed ID: 27923955 [Abstract] [Full Text] [Related]
26. The changing epidemiology of hospitalized pediatric patients in three measles outbreaks. Lee KY, Lee HS, Hur JK, Kang JH, Lee BC. J Infect; 2007 Feb 15; 54(2):167-72. PubMed ID: 16620998 [Abstract] [Full Text] [Related]
27. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T, Baer M, Willems P. Pediatr Infect Dis J; 2007 Feb 15; 26(2):153-8. PubMed ID: 17259879 [Abstract] [Full Text] [Related]
28. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C. Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798 [Abstract] [Full Text] [Related]
29. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N. Vaccine; 2012 Jun 13; 30(28):4292-8. PubMed ID: 22521285 [Abstract] [Full Text] [Related]
30. Spotlight on measles 2010: measles outbreak in a mainly unvaccinated community in Essen, Germany, March-June 2010. Roggendorf H, Mankertz A, Kundt R, Roggendorf M. Euro Surveill; 2010 Jul 01; 15(26):. PubMed ID: 20619132 [Abstract] [Full Text] [Related]
31. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. J Infect Dis; 2008 Apr 01; 197(7):950-6. PubMed ID: 18419470 [Abstract] [Full Text] [Related]
32. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P. Pediatr Infect Dis J; 2008 Aug 01; 27(8):724-30. PubMed ID: 18600190 [Abstract] [Full Text] [Related]
33. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. St Sauver JL, Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. Hum Immunol; 2005 Jul 01; 66(7):788-98. PubMed ID: 16112026 [Abstract] [Full Text] [Related]
34. Rubella elimination programme strengthened through measles elimination programme in Catalonia. Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L. Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357 [Abstract] [Full Text] [Related]
35. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Bone Marrow Transplant; 2004 Jun 27; 33(12):1187-90. PubMed ID: 15077129 [Abstract] [Full Text] [Related]
36. Response to measles-mumps-rubella vaccine in children with autism spectrum disorders. Gentile I, Bravaccio C, Bonavolta R, Zappulo E, Scarica S, Riccio MP, Settimi A, Portella G, Pascotto A, Borgia G. In Vivo; 2013 Jun 27; 27(3):377-82. PubMed ID: 23606694 [Abstract] [Full Text] [Related]
37. Australian population cohort study of newly arrived refugee children: how effective is predeparture measles and rubella vaccination? Joshua PR, Smith MM, Koh AS, Woodland LA, Zwi K. Pediatr Infect Dis J; 2013 Feb 27; 32(2):104-9. PubMed ID: 22955722 [Abstract] [Full Text] [Related]
38. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, Iannilli A, d'Annunzio G, Iafusco D, Songini M, Toni S, Cherubini V, Carle F, RIDI Study Group. Diabet Med; 2012 Jun 27; 29(6):761-6. PubMed ID: 22133003 [Abstract] [Full Text] [Related]
39. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study. Avijgan M, Hafizi M, Moghni M, Kheiri S, Esteghamati A, Sarikhani S. East Afr J Public Health; 2011 Jun 27; 8(2):88-91. PubMed ID: 22066292 [Abstract] [Full Text] [Related]
40. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 27; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]